Salim Syed
Stock Analyst at Mizuho
(0.61)
# 2489
Out of 5,370 analysts
81
Total ratings
37.93%
Success rate
-9.28%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
NKTX Nkarta | Maintains: Outperform | 16 14 | 1.89 | 640.74% | 8 | Jun 10, 2025 | |
CYTK Cytokinetics | Maintains: Outperform | 103 84 | 33.75 | 148.89% | 7 | May 29, 2025 | |
BIIB Biogen | Maintains: Outperform | 207 169 | 131.07 | 28.94% | 16 | May 7, 2025 | |
AMGN Amgen | Maintains: Neutral | 235 280 | 295.12 | -5.12% | 8 | May 7, 2025 | |
GILD Gilead Sciences | Maintains: Outperform | 100 117 | 110.72 | 5.67% | 7 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 19 22 | 6.84 | 221.64% | 5 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 113 163 | 34.23 | 376.19% | 3 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 25 18 | 8.55 | 110.53% | 4 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 34 | 23.07 | 47.38% | 1 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 82 99 | 41.66 | 137.64% | 3 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 60 53 | 41.04 | 29.14% | 7 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 6 | 0.81 | 640.74% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 28 21 | 0.78 | 2592.31% | 5 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 168 36 | 17.14 | 110.04% | 1 | Nov 16, 2022 |